/
Clinical Visual Analytics for Review and Submission (CVARS)

Clinical Visual Analytics for Review and Submission (CVARS)

Project Scope

Development of an open-source tool and package to enable generation of identified interactive plots for clinical review and direct inclusion in submissions to regulatory agencies. The initial scope is to develop a package to generate interactive forest and volcano plots for adverse events and FDA Medical Queries (FMQs) analysis outputs for inclusion in submissions to the FDA. This work is a collaboration among the American Statistical Association (ASA), PHUSE and the FDA.

Project Leads

Email

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Jiang (Jessica) Hu, FDA

jiang.hu@fda.hhs.gov

Neetu Sangari, Pragya Tech Leadersneetusang@gmail.com
Alex Pearce, PHUSE Project Assistant

alexandra@phuse.global

CURRENT STATUS Q4 2024

  • Updated CVARS version with E2E implementation and shinylive deployment.
  • Final manuscript for CVARS E2E implementation.
Objectives & DeliverablesTimelines
An open-source R Shiny tool for generating the plots and associated outputs and an accompanying paper for the toolQ3 2022
Complete manuscriptQ4 2024


Related content

Data Visualisation & Open Source Technology
Data Visualisation & Open Source Technology
More like this
Communication of Version Metadata for Open-Source Languages
Communication of Version Metadata for Open-Source Languages
Read with this
Data Visualisation & Open Source Technology – Project Volunteer Board
Data Visualisation & Open Source Technology – Project Volunteer Board
More like this
Demonstrating Real-World Impact of Modernization of Statistical Analytics (MSA) Framework
Demonstrating Real-World Impact of Modernization of Statistical Analytics (MSA) Framework
Read with this
Safety Analytics Webinar Series: Overall Safety Assessment – Interactive Safety Graphics for Regulatory Decision-Making
Safety Analytics Webinar Series: Overall Safety Assessment – Interactive Safety Graphics for Regulatory Decision-Making
More like this
Hot Topics
Hot Topics
Read with this